Netris Pharma starts hepatocellular carcinoma study
26 Jan 2023 //
PHARMATIMES
NETRIS Pharma begins subject dosing in solid tumour therapy trial
30 Nov 2022 //
CLINICALTRIALSARENA
NETRIS Pharma Doses First Patient in Phase 2 Study of NP137
28 Nov 2022 //
BUSINESSWIRE